FDA Believed Poised to Approve First Med for a Serious Liver Disease
Regulation
FDA Believed Poised to Approve First Med for a Serious Liver Disease
2024-03-13 16:49:07
by Dan McCue

WASHINGTON — The Food and Drug Administration appears poised to approve the first medicine developed specifically to treat the serious liver disease known as MASH later this week.  Metabolic dysfunction-associated steatohepatitis -- formerly known as nonalcoholic steatohepatitis — is often... Read More

Theories Emerge for Mysterious Liver Illnesses in Children
Health
Theories Emerge for Mysterious Liver Illnesses in Children

NEW YORK (AP) — Health officials remain perplexed by mysterious cases of severe liver damage in hundreds of young children around the world. The best available evidence points to a fairly common stomach bug that isn't known to cause liver... Read More

Straight From The Well
scroll top